Pfizer (PFE) Stock Price
$25.55 2.3%
to add to portfolio
AI Score

-
Alternative
2 -
Fundamental
5 -
Technical
4
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Pfizer, AI stock picks, stock alerts and much more.
PFE AI Stock Analysis
AI stock analysis for PFE is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Pfizer (PFE) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Pfizer (PFE) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Pfizer (PFE), currently trading at $25.55, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About PFE

-
Pfizer Inc.
-
Symbol
PFE
-
Market
NYSE
-
Industry
Drug Manufacturers - General
-
Market Cap
144.9B
Similar Stocks
![]() |
Johnson & Johnson JNJ |
$161 1.4% |
5 |
![]() |
Eli Lilly and Company LLY |
$852.4 1.5% |
7 |
![]() |
AbbVie ABBV |
$201.3 3.7% |
5 |
![]() |
Merck & Company MRK |
$87.87 4.8% |
5 |
![]() |
Novartis NVS |
$110.4 0.6% |
5 |
News
PFE Alternative Data
Web Traffic
Pfizer receives an estimated 1.5M monthly visitors to pfizer.com.
-
Web Traffic
1535249
-
Change from Previous Month
8.4%
-
3 Month Change
0.6%
-
YoY Change
0.6%
News Mentions
Pfizer was mentioned 40 times in the news yesterday.
-
News Mentions
40
-
Daily Change
53.8%
-
1 Month Change
233.3%
-
3 Month Change
233.3%
Reddit Mentions
Pfizer has been mentioned an estimated 15 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
15
-
Daily Change
400%
-
1 Month Change
150%
Twitter Followers
Pfizer has 480,616 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.1% over the last month.
-
Twitter Followers
480616
-
Daily Change
0%
-
1 Month Change
0.1%
-
3 Month Change
0.5%
-
YoY Change
0.5%
Facebook Engagement
Pfizer has engaged 19,101 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
19101
-
Daily Change
2.2%
-
1 Month Change
65.9%
-
3 Month Change
54.5%
-
YoY Change
54.5%
Youtube Subscribers
Pfizer has 15 subscribers on its main Youtube channel.
-
Youtube Subscribers
15
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
LinkedIn Followers
6,206,681 are following Pfizer on LinkedIn, up by 0.6% over the last month.
-
LinkedIn Followers
6206681
-
Daily Change
0%
-
1 Month Change
0.6%
-
3 Month Change
1.9%
Job Postings
Pfizer currenly has an estimated 649 open job postings, up by 31.9% over the last month.
-
Job Postings
649
-
Daily Change
3.7%
-
1 Month Change
31.9%
-
3 Month Change
16.3%
-
YoY Change
16.3%
Instagram Followers
Pfizer has 123,405 Instagram Followers on its main Instagram account, down by -0.1% over the last month.
-
Instagram Followers
123405
-
Daily Change
0%
-
1 Month Change
0.1%
-
3 Month Change
0.1%
-
YoY Change
0.1%
LinkedIn Employees
According to LinkedIn, Pfizer has 102,541 employees, down by -0% over the last month.
-
LinkedIn Employees
102541
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0.3%
-
YoY Change
0.3%
Business Outlook
According to employee reviews, the business outlook among employees at Pfizer is 55 out of 100 (neutral).
-
Business Outlook
55
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
PFE Financials
PFE Key Metrics
-
Total Revenue
$17.8B
-
Net Income
$410M
-
Earnings per Share
$0.0723
-
Free cash flow
$5.8B
-
EBITDA
$2.5B
-
EBITDA Ratio
0.141868
-
Total Assets
$213.4B
PFE 2-year Revenue & Income
PFE 2-year Free Cash Flow
PFE Technicals
PFE SMA
PFE RSI
FAQ
What's the current price of Pfizer (PFE) Stock?
The price of an Pfizer (PFE) share is $25.55.
What's the market cap of Pfizer?
The current market cap of Pfizer is 144.9B.
Should I buy or sell PFE?
Pfizer exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.
Is Pfizer a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in Pfizer stock. There are several bearish signals and market challenges that could negatively impact Pfizer's future performance, suggesting that caution should be exercised before making any investment decisions.
Is now a good time to buy Pfizer (PFE) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy Pfizer stock right now, as the outlook appears bearish.
What are some stocks similar to Pfizer (PFE) that investors often compare it to?
Pfizer (PFE) is often compared to similar stocks such as Johnson & Johnson, Eli Lilly and Company, AbbVie, Merck & Company and Novartis.
What is the forecast for Pfizer's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Pfizer's stock price to be around $23.55 in 2026. Starting from the current price of $25.55, this represents a 7.8% change in price, indicating a bearish outlook for the stock.
How to buy Pfizer (PFE) Stock?
Pfizer stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Pfizer shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.